Open Access

Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues

  • Hossein Ajdarkosh1,
  • Masoomeh Dadpay2,
  • Emad Yahaghi3,
  • Elham Rostami Pirzaman4,
  • Amir Farshid Fayyaz5,
  • Ebrahim Khodaverdi Darian6 and
  • Aram Mokarizadeh7Email author
Diagnostic Pathology201611:105

https://doi.org/10.1186/s13000-016-0561-8

Received: 17 October 2016

Accepted: 19 October 2016

Published: 2 November 2016

The original article was published in Diagnostic Pathology 2015 10:135

Retraction

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Gastrointestinal and Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences
(2)
Department of Pathology, Imam Reza Hospital, AJA University of Medical Sciences
(3)
Baqiyatallah University of Medical Sciences
(4)
Department of Biotechnology and Nanotechnology, Zanjan University of Medical Sciences
(5)
Department of Legal Medicine, AJA University of Medical Sciences
(6)
Young Researchers and Elite Club, Karaj Branch, Islamic Azad University
(7)
Cellular & Molecular Research Center, Kurdistan University of Medical Sciences

References

  1. Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol. 2015;10:135.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Zhang SL, Liu L. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. Exp Ther Med. 2014;9(2):579–84.PubMedPubMed CentralGoogle Scholar
  3. Zhang J-G, Shi Y, Hong D-F, Song M, Huang D, Wang C-Y, Zhao G. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Sci Rep. 2015;5:8087.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement